Gregory Sullivan
2021
In 2021, Gregory Sullivan earned a total compensation of $2.2M as Chief Medical Officer at Tonix Pharmaceuticals Holding, a 63% increase compared to previous year.
Compensation breakdown
| Bonus | $176,000 |
|---|---|
| Option Awards | $1,631,785 |
| Salary | $440,000 |
| Total | $2,247,785 |
Sullivan received $1.6M in option awards, accounting for 73% of the total pay in 2021.
Sullivan also received $176K in bonus and $440K in salary.
Rankings
In 2021, Gregory Sullivan's compensation ranked 5,589th out of 12,406 executives tracked by ExecPay. In other words, Sullivan earned more than 54.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,589 out of 12,406 | 55th |
Division Manufacturing | 2,364 out of 5,492 | 57th |
Major group Chemicals And Allied Products | 1,025 out of 2,368 | 57th |
Industry group Drugs | 914 out of 2,089 | 56th |
Industry Pharmaceutical Preparations | 659 out of 1,536 | 57th |
Source: SEC filing on March 18, 2022.
Sullivan's colleagues
We found three more compensation records of executives who worked with Gregory Sullivan at Tonix Pharmaceuticals Holding in 2021.
News
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2023 pay falls 55% to $2.1M
April 15, 2024
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2022 pay falls 41% to $4.6M
March 17, 2023
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2021 pay jumps 99% to $7.7M
March 18, 2022
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2020 pay jumps 201% to $3.9M
March 31, 2021
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2019 pay slips 13% to $1.3M
March 30, 2020
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2018 pay jumps 157% to $1.5M
March 18, 2019